Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,422 | 207 | 99.4% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $20.00 | 1 | 0.6% |
| Education | $1.02 | 1 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AbbVie Inc. | $537.89 | 27 | $0 (2021) |
| AstraZeneca Pharmaceuticals LP | $440.21 | 31 | $0 (2021) |
| Amgen Inc. | $335.29 | 16 | $0 (2021) |
| Novo Nordisk Inc | $310.91 | 19 | $0 (2021) |
| Lilly USA, LLC | $249.71 | 20 | $0 (2021) |
| GlaxoSmithKline, LLC. | $240.87 | 20 | $0 (2018) |
| PFIZER INC. | $141.77 | 10 | $0 (2021) |
| Merck Sharp & Dohme Corporation | $132.54 | 10 | $0 (2021) |
| Lucid Diagnostics Inc. | $93.28 | 1 | $0 (2021) |
| Allergan, Inc. | $86.93 | 5 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $20.30 | 1 | Exact Sciences Corporation ($20.30) |
| 2021 | $1,199 | 62 | AbbVie Inc. ($367.23) |
| 2020 | $594.11 | 35 | Novo Nordisk Inc ($110.51) |
| 2019 | $541.84 | 35 | AstraZeneca Pharmaceuticals LP ($162.09) |
| 2018 | $444.65 | 33 | GlaxoSmithKline, LLC. ($113.42) |
| 2017 | $643.32 | 43 | GlaxoSmithKline, LLC. ($127.45) |
All Payment Transactions
209 individual payment records from CMS Open Payments — Page 1 of 9
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 02/15/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $20.30 | General |
| Category: Oncology | ||||||
| 12/09/2021 | Biohaven Pharmaceuticals, Inc. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $19.95 | General |
| Category: PRIMARY CARE | ||||||
| 12/07/2021 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $23.36 | General |
| Category: NEUROSCIENCE | ||||||
| 12/06/2021 | Lucid Diagnostics Inc. | — | Food and Beverage | In-kind items and services | $93.28 | General |
| 12/01/2021 | Amgen Inc. | Aimovig (Biological), Otezla, Repatha | Food and Beverage | In-kind items and services | $24.35 | General |
| Category: Neuroscience | ||||||
| 11/30/2021 | Merck Sharp & Dohme Corporation | GARDASIL 9 (Biological), PNEUMOVAX 23, VAXNEUVANCE | Food and Beverage | In-kind items and services | $12.83 | General |
| Category: VACCINE | ||||||
| 11/17/2021 | Biohaven Pharmaceuticals, Inc. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $14.58 | General |
| Category: PRIMARY CARE | ||||||
| 11/16/2021 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $26.68 | General |
| Category: NEUROSCIENCE | ||||||
| 11/10/2021 | Hologic, LLC | THINPREP 2000 PROCESSOR (Device) | Food and Beverage | In-kind items and services | $20.93 | General |
| Category: Diagnostics | ||||||
| 11/04/2021 | Novo Nordisk Inc | RYBELSUS (Drug), Ozempic | Food and Beverage | In-kind items and services | $18.23 | General |
| Category: Diabetes | ||||||
| 11/04/2021 | AbbVie Inc. | SYNTHROID (Drug) | Food and Beverage | In-kind items and services | $13.29 | General |
| Category: IMMUNOLOGY | ||||||
| 11/03/2021 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $12.53 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/28/2021 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $92.44 | General |
| Category: NEUROSCIENCE | ||||||
| 10/26/2021 | Lilly USA, LLC | TRULICITY (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $10.44 | General |
| Category: Diabetes | ||||||
| 10/19/2021 | Novo Nordisk Inc | RYBELSUS (Drug), Ozempic | Food and Beverage | In-kind items and services | $18.27 | General |
| Category: Diabetes | ||||||
| 10/14/2021 | Eisai Inc. | Dayvigo (Drug) | Food and Beverage | Cash or cash equivalent | $20.89 | General |
| Category: Neurology | ||||||
| 09/30/2021 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $21.69 | General |
| Category: NEUROSCIENCE | ||||||
| 09/22/2021 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $14.18 | General |
| Category: Respiratory | ||||||
| 09/16/2021 | Biohaven Pharmaceuticals, Inc. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $34.21 | General |
| Category: PRIMARY CARE | ||||||
| 09/02/2021 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $18.55 | General |
| Category: NEUROSCIENCE | ||||||
| 08/24/2021 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $21.29 | General |
| Category: Diabetes | ||||||
| 08/19/2021 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $18.96 | General |
| Category: NEUROSCIENCE | ||||||
| 08/16/2021 | PFIZER INC. | ELIQUIS (Drug), COLOGUARD DNA CAPTURE REAGENTS | Food and Beverage | In-kind items and services | $12.63 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 08/12/2021 | AbbVie Inc. | SYNTHROID (Drug) | Food and Beverage | In-kind items and services | $17.10 | General |
| Category: IMMUNOLOGY | ||||||
| 08/09/2021 | Lilly USA, LLC | TRULICITY (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $10.79 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 12 | 830 | 977 | $385,039 | $83,464 |
| 2022 | 11 | 652 | 785 | $302,015 | $67,095 |
| 2021 | 16 | 928 | 2,360 | $204,111 | $97,971 |
| 2020 | 19 | 1,073 | 1,355 | $181,255 | $77,271 |
All Medicare Procedures & Services
58 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 183 | 273 | $139,776 | $23,207 | 16.6% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 174 | 174 | $90,828 | $22,625 | 24.9% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 66 | 66 | $46,392 | $18,555 | 40.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 135 | 185 | $66,785 | $10,884 | 16.3% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 47 | 47 | $15,094 | $3,360 | 22.3% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 66 | 66 | $9,996 | $2,049 | 20.5% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 46 | 46 | $7,060 | $1,428 | 20.2% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 52 | 58 | $2,058 | $487.20 | 23.7% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 13 | 14 | $3,150 | $394.69 | 12.5% |
| 90471 | Administration of vaccine | Office | 2023 | 17 | 17 | $2,159 | $232.18 | 10.8% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 13 | 13 | $1,183 | $139.92 | 11.8% |
| 82043 | Urine microalbumin (protein) level | Office | 2023 | 18 | 18 | $558.00 | $101.88 | 18.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 159 | 227 | $110,921 | $20,420 | 18.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 145 | 145 | $75,690 | $19,503 | 25.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 125 | 188 | $63,877 | $12,224 | 19.1% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2022 | 22 | 22 | $7,816 | $6,117 | 78.3% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 39 | 39 | $12,300 | $2,663 | 21.7% |
| 90732 | Pneumococcal vaccine, 23-valent | Office | 2022 | 18 | 18 | $11,368 | $2,376 | 20.9% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 48 | 49 | $7,158 | $1,483 | 20.7% |
| G0009 | Administration of pneumococcal vaccine | Office | 2022 | 38 | 38 | $5,252 | $1,153 | 22.0% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2022 | 11 | 11 | $3,553 | $772.75 | 21.7% |
| 90471 | Administration of vaccine | Office | 2022 | 27 | 27 | $3,429 | $263.37 | 7.7% |
| 82043 | Urine microalbumin (protein) level | Office | 2022 | 20 | 21 | $651.00 | $119.64 | 18.4% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 228 | 333 | $71,550 | $28,142 | 39.3% |
| J0897 | Injection, denosumab, 1 mg | Office | 2021 | 16 | 1,200 | $28,525 | $18,319 | 64.2% |
About Dr. Robert Knepshield, MD
Dr. Robert Knepshield, MD is a Family Medicine healthcare provider based in Lone Tree, Colorado. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/26/2009. The National Provider Identifier (NPI) number assigned to this provider is 1700026051.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Robert Knepshield, MD has received a total of $3,443 in payments from pharmaceutical and medical device companies, with $20.30 received in 2024. These payments were reported across 209 transactions from 35 companies. The most common payment nature is "Food and Beverage" ($3,422).
As a Medicare-enrolled provider, Knepshield has provided services to 3,483 Medicare beneficiaries, totaling 5,477 services with total Medicare billing of $325,801. Data is available for 4 years (2020–2023), covering 58 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Lone Tree, CO
- Active Since 02/26/2009
- Last Updated 12/16/2021
- Taxonomy Code 207Q00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1700026051
Products in Payments
- FARXIGA (Drug) $342.09
- UBRELVY (Drug) $237.33
- Ozempic (Drug) $148.05
- Aimovig (Biological) $131.69
- Synthroid (Drug) $123.18
- TRULICITY (Drug) $120.89
- BREO (Drug) $112.62
- Prolia (Biological) $107.50
- SYNTHROID (Drug) $107.06
- EMGALITY (Drug) $102.53
- VRAYLAR (Drug) $101.68
- Saxenda (Drug) $87.79
- NURTEC ODT (Drug) $85.17
- ELIQUIS (Drug) $80.02
- Repatha (Biological) $73.52
- SYMBICORT (Drug) $66.48
- JANUVIA (Drug) $65.50
- Dayvigo (Drug) $64.51
- Uloric (Drug) $63.98
- TRADJENTA (Drug) $55.22
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Lone Tree
Dr. Dennis Furr, D.o, D.O
Family Medicine — Payments: $20,150
Dr. Ann Linares, M.d, M.D
Family Medicine — Payments: $5,268
Chandra Marshall, D.o, D.O
Family Medicine — Payments: $4,553
Dr. Christine Jones, D.o, D.O
Family Medicine — Payments: $4,219
Dr. Chester Cedars, M.d, M.D
Family Medicine — Payments: $3,083
Marina Ivashchenko, Md, MD
Family Medicine — Payments: $2,967